Daniel Sulmasy to Clinical Trials as Topic
This is a "connection" page, showing publications Daniel Sulmasy has written about Clinical Trials as Topic.
Connection Strength
1.680
-
Are SARS-CoV-2 Human Challenge Trials Ethical? JAMA Intern Med. 2021 08 01; 181(8):1031-1032.
Score: 0.481
-
Perceptions of control and unrealistic optimism in early-phase cancer trials. J Med Ethics. 2018 02; 44(2):121-127.
Score: 0.365
-
Unrealistic optimism in early-phase oncology trials. IRB. 2011 Jan-Feb; 33(1):1-8.
Score: 0.231
-
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer. 2010 Aug 01; 116(15):3702-11.
Score: 0.224
-
Cancer, managed care, and therapeutic research: an ethicist's view. HMO Pract. 1997 Jun; 11(2):59-62.
Score: 0.090
-
The Impact of Unrealistic Optimism on Informed Consent in Early-Phase Oncology Trials. IRB. 2016 Sep-Oct; 38(5):1-7.
Score: 0.086
-
Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent. Med Decis Making. 2008 Jul-Aug; 28(4):575-81.
Score: 0.048
-
The clinician as investigator: participating in clinical trials in the practice setting. Circulation. 2004 Jun 01; 109(21):2672-9.
Score: 0.037
-
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design. Circulation. 2004 Jun 01; 109(21):e302-4.
Score: 0.037
-
The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis. Circulation. 2004 Jun 01; 109(21):e305-7.
Score: 0.037
-
The call of the sirens: ethically navigating the sea of nonvalidated therapies. J Refract Surg. 1998 Sep-Oct; 14(5):559-66.
Score: 0.025
-
Dispositional optimism and therapeutic expectations in early-phase oncology trials. Cancer. 2016 Apr 15; 122(8):1238-46.
Score: 0.021